Platelet function following induced hypoglycaemia in type 2 diabetes
Kahal, H.; Aburima, A.; Spurgeon, B.; Wraith, K. S.; Rigby, A. S.; Sathyapalan, T.; Kilpatrick, E. S.; Naseem, K. M.; Atkin, S. L.
K. S. Wraith
A. S. Rigby
E. S. Kilpatrick
K. M. Naseem
S. L. Atkin
Strict glycaemic control has been associated with an increased mortality rate in subjects with type 2 diabetes (T2DM). Here we examined platelet function immediately and 24 hours following induced hypoglycaemia in people with type 2 diabetes compared to healthy age-matched controls.
Hyperinsulinaemic clamps reduced blood glucose to 2.8 mmol/L (50 mg/dl) for 1 hour. Sampling at baseline; euglycaemia 5mmol/L (90 mg/dl); hypoglycaemia; and at 24 post clamp were undertaken. Platelet function was measured by whole blood flow cytometry.
10 subjects with T2DM and 8 controls were recruited. Platelets from people with T2DM showed reduced sensitivity to prostacyclin (PGI2, 1 nM) following hypoglycaemia. The ability of PGI2 to inhibit platelet activation was significantly impaired at 24 hours compared to baseline in the T2DM group. Here, inhibition of fibrinogen binding was 29.5% (10.3 – 43.8) compared to 50.8% (36.8 – 61.1), (P < 0.05), while inhibition of P-selectin expression was 32% (16.1 – 47.6) vs. 54.4% (42.5 – 67.5) (P < 0.05). No significant changes in platelet function were noted in controls.
Induced hypoglycaemia in T2DM enhances platelet hyperactivity through impaired sensitivity to prostacyclin at 24 hours.
Kahal, H., Aburima, A., Spurgeon, B., Wraith, K. S., Rigby, A. S., Sathyapalan, T., …Atkin, S. L. (2018). Platelet function following induced hypoglycaemia in type 2 diabetes. Diabetes & metabolism, 44(5), 431-436. https://doi.org/10.1016/j.diabet.2018.04.004
|Journal Article Type||Article|
|Acceptance Date||Apr 18, 2018|
|Online Publication Date||May 3, 2018|
|Publication Date||Nov 1, 2018|
|Deposit Date||May 6, 2018|
|Publicly Available Date||May 4, 2019|
|Journal||Diabetes & Metabolism|
|Peer Reviewed||Peer Reviewed|
|Keywords||Internal Medicine; Endocrinology, Diabetes and Metabolism; Endocrinology; General Medicine|
|Copyright Statement||© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/|
Publisher Licence URL
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
The metabolic and proteomic signatures of hypoglycemia in type 2 diabetes